June 30 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* REG-ADDEX ESTABLISHES AT-THE-MARKET ADS EQUITY SALE
PROGRAM
* COMPANY HAS ENTERED INTO A SALES AGREEMENT WITH CANTOR
FITZGERALD, TO OFFER AMERICAN DEPOSITARY SHARES (ADSS), EACH
REPRESENTING SIX SHARES WITH NO NOMINAL VALUE THROUGH AN
"AT--MARKET" (ATM) OFFERING PROGRAM
* INTENDS TO USE NET PROCEEDS FROM ATM PROGRAM TO ADVANCE
DEVELOPMENT OF ITS PORTFOLIO OF PROPRIETARY ALLOSTERIC MODULATOR
DRUG CANDIDATES
Source text for Eikon: ID:nGNE1nG9l9
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))